Real-time enrollment status for this hepatic impairment clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:07 PM UTC
| NCT Number | NCT05484206 |
| Recruiting Status | Recruiting |
| Condition | Hepatic Impairment |
| Phase | PHASE1 |
| Target Enrollment | 144 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Vir Biotechnology, Inc. |
| Last Updated on CT.gov | June 13, 2025 (Jun 13, 2025) |
As of August 28, 2026: Clinical trial NCT05484206 is currently recruiting participants. This phase1 study for hepatic impairment is actively seeking new participants at 5 locations across the United States. The study is sponsored by Vir Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05484206 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05484206 was last updated Jun 13, 2025 (June 13, 2025). HelloStudys verifies this status automatically.